TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
26/03/2026
Voltar para busca
Dado oficial do USPTO
KOLMAR
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
37
Atualização mais recente
28/03/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5
Data de depósito
14/04/2022
Data de registro
04/06/2024
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
04/06/2024
Última transação
28/03/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Código do desenho
4
Tipo de titular
03
Localização do titular
SEJONG-SI, KR
Examinador
BUTTON, JENNIFER JO
Localização atual
FILE REPOSITORY (FRANCONIA)
Titulares e representantes
Titulares
KOLMAR HOLDINGS CO., LTD.
KOLMAR KOREA HOLDINGS CO., LTD.
Representantes
David Youngjoon Jung KAIROS Law Firm, PLLC
Classificação técnica
Classes Nice
Classe 5
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Nutraceuticals for use as a dietary supplement; nutraceutical preparations for therapeutic or medical purposesnutraceutical preparations for the treatment of immune system related diseases and disordersinfectious diseasesmetabolic diseaseskidney diseasesliver diseasesgastrointestinal diseasesinflammatory diseasescancer and oncologic disordersskin diseases and disorderscardiovascular diseasesrespiratory diseasesallergic diseasesneurological disorders and conditionspsychiatric disorders; dietary supplements; probiotic bacterial formulations for medical use; nutraceutical preparations mainly based on lactic acid bacteria; probiotic preparations for medical use; dietary supplements for humans; lacteal flour for babies; household deodorants; Medicines for human purposesfor the treatment and relief of inflammation and inflammatory diseases and disorders; Medicines for human purposesantioxidants; Medicines for human purposespreparations for the treatment of allergieshay fevermotion sicknessdermatologic usethe treatment of dermatitisskin pigmentation diseasestreatment of cold sorestreatment and prevention of dry skineczemapsoriasisacnefor the treatment of atopic skinthe treatment of sunburnirritated skincrackingcracksinsect bitesminor woundsrasheswartsfor the treatment of diseases and symptoms within the central nervous systemanxietyspasmssleep disordersnervousnessirritabilitynervesapprehensivenessemotional palpitationsfor the treatment of disorders and conditions involving the jointsmusclestendons and ligamentsfor the treatment of joint painmusclemuscle fatiguecrampsfatigue statesfor the treatment of toothachefor the treatment of infections of the mouthfor the treatment of bruisesbumpsachespainfeverheadachesvitamin-based nutritional supplements and mineral supplements; Medicines for human purposesbacterial and bacteriological preparations for medical purposes; disposable baby diapers; vitamin preparations; mineral food supplements; cultures of microorganisms for medical use; Dietetic substancesinfant formula and food for babies adapted for medical use; Dietetic substancesbeverages and food adapted for medical use; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparation for skin care; Pharmaceutical preparations for treatment of hepatitis; Pharmaceutical preparations for the treatment of musculoskeletal disorders; Pharmaceutical preparations for the treatment of diseases of the endocrine system; Pharmaceutical preparations for urogenital organs; Cardiovascular pharmaceutical preparations; Pharmaceutical preparations for the treatment of kidney diseases; Pharmaceutical preparationsmedicated toiletry preparationsmedicated soapsskin lotions for pharmaceutical purposes; Pharmaceutical preparations for respiratory organs; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceuticalsantioxidants; Pharmaceutical agents affecting digestive organs; Pharmaceuticalsantibiotics and anti-infectives for the treatment and prevention of infectious diseases and obesityfat and cholesterol controlblood sugar control and strengthening of immune system; Pharmaceuticals preparations and substances for the treatment of paininflammationdamaged skin and tissues and wounds; Pharmaceuticals preparations and substances for use in treating dermatitiseczemapsoriasisulcerating woundsskin diseasesskin conditions and lesions; Pharmaceutical skin lotions; probiotic supplements; preparations of microorganisms for medical or veterinary use; nutritional supplements
Publicações
Histórico de despachos e eventos da marca no USPTO.
37 publicações encontradas
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
26/03/2026
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
26/03/2026
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
26/03/2026
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
17/06/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
17/06/2025
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
17/06/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
17/06/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
17/06/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
17/06/2025
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
17/06/2025
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
06/06/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
04/06/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
04/06/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
19/03/2024
PUBO
PUBLISHED FOR OPPOSITION
19/03/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
28/02/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
28/02/2024
OTHE
CASE RETURNED TO EXAMINATION
16/01/2024
IUCN
NOTICE OF ALLOWANCE CANCELLED
16/01/2024
JURT
JURISDICTION RESTORED TO EXAMINING ATTORNEY
07/12/2023
PCBG
PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
07/12/2023
APET
ASSIGNED TO PETITION STAFF
07/12/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
10/11/2023
EX1G
SOU EXTENSION 1 GRANTED
08/11/2023
EXT1
SOU EXTENSION 1 FILED
08/11/2023
EEXT
SOU TEAS EXTENSION RECEIVED
08/11/2023
EPPA
TEAS POST PUBLICATION AMENDMENT RECEIVED
08/11/2023
TPAD
TEAS PETITION TO AMEND BASIS RECEIVED
08/11/2023
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
09/05/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
14/03/2023
PUBO
PUBLISHED FOR OPPOSITION
14/03/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
22/02/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/02/2023
DOCK
ASSIGNED TO EXAMINER
31/01/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
20/04/2022
NWAP
NEW APPLICATION ENTERED
18/04/2022
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace KOLMAR ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.